$1,000 invested Johnson & Johnson (2016)
NYSE · JNJ · reinvest dividends · adjusted close
●Result2016-01-04 — 2026-10-15
Today you would have
$3,343
+$2,343 (+234.27%)
JNJSPY (benchmark)
- Entry price
- $75.77
- Current price
- $253.28
- Shares
- 13.1977
- CAGR
- +11.85%
- Max Drawdown
- -27.37%
- vs SPY
- -119.97 pp
✦The story
$1,000 put into Johnson & Johnson in early 2016 was worth $3,343 by mid-2026, a total return of +234.3%. The diversified healthcare company delivered steady growth through its pharmaceutical, medical device and consumer segments, later spinning off the consumer arm as Kenvue. Even so, the S&P 500 did better over the same decade, returning +354.2%.
#Related scenariosfor comparison
Other years for JNJ